Pfizer Surges! ₹189 Cr Profit, Record Dividend & Asset Sale Boost Q2 Performance - Investors Rejoice!

Pfizer Limited announced robust financial results for the September quarter of FY26, showcasing significant year-on-year growth. Net profit surged by 19.4% to ₹189 crore, up from ₹158 crore in the same period last year, driven by strong sales and enhanced operational efficiencies. Revenue from operations increased by 9.1% to ₹642.3 crore, indicating sustained demand across its key pharmaceutical segments. Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) saw a substantial rise of 21.5% to ₹229.8 crore, with EBITDA margins improving to 35.8% from 32.1%, attributed to effective cost optimization measures. A notable event during the quarter was the completion of the sale of leased land and building assets in Maharashtra, approved by the Maharashtra Industrial Development Corporation (MIDC). This transaction resulted in a net gain of ₹172.81 crore, recognized as an exceptional item in the company's financials. In line with its performance and shareholder returns, the company's annual general meeting approved a total dividend payout of ₹165 per equity share. This includes a ₹35 final dividend, a ₹100 special dividend celebrating 75 years in India, and an additional ₹30 special dividend tied to the MIDC asset sale gain. The dividend was paid out on July 25, 2025.

Impact This news indicates strong operational performance and strategic financial management by Pfizer Limited. The improved profitability, revenue growth, and substantial dividend payout, including one linked to asset monetization, are positive signals for shareholders and the pharmaceutical sector. The market may react positively to the company's financial health and its commitment to returning value to investors. Impact rating: 7/10

Difficult terms: * Net Profit: The profit a company makes after deducting all its expenses, including taxes and interest. * Revenue from Operations: The total income generated from the company's core business activities before deducting expenses. * EBITDA: Earnings Before Interest, Taxes, Depreciation, and Amortization. A measure of a company's operating performance. * EBITDA Margins: EBITDA expressed as a percentage of revenue, indicating operational profitability. * Exceptional Item: A material item of income or expense that arises from events or transactions outside of the ordinary course of business. * Dividend: A distribution of a portion of a company's earnings to its shareholders.